Factors Associated With Posttransplant Cardiac Outcomes
Recruiting
Observational Study
Cardiovascular Diseases
Liver Transplantation
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Sun Yat-sen University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cardiovascular disease has become the leading cause of death early after liver transplantation (LT). The aging LT population is accompanied with the increasing prevalence of cardiovascular risk factors such as hypertension, diabetes, and hyperlipidemia. Furthermore, cirrhosis has been known to cause alterations in the systemic haemodynamic system and cardiac muscle dysfunction, systolic and/or dia…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \> 18 years,
* End-stage cirrhosis patients who will receive liver transplantation,
* Patients voluntarily take part in the study and write informed consent.
Exclusion Criteria:
* Decreased left ventricular systolic function (ejection fraction \<45%),
* Significant uncor…
Contacts